What's holding MedTech startups back

MedTech teams operate at the intersection of clinical, commercial and regulatory demands, often with very long, nonlinear sales cycles. Without strong RevOps, data is scattered, handoffs are fragile and leadership struggles to understand what is really in the pipeline.

• Complex stakeholder maps across clinicians, procurement and management
• Trials, pilots and evaluations not tracked consistently
• Weak visibility on time to close and reasons for delay
• Manual reporting for boards and investors
• Regional variation in processes and tools across teams